IL-33 Mouse mAb - Primary antibody, specific to IL33, Mouse IgG2a

    Application:
  • IHC
  • WB
Features and benefits
  • Host species: Mouse
  • Species reactivity(Reacts with): Human,Mouse,Rat
  • Isotype: Mouse IgG2a
  • Clone Number: C11
  • Conjugation: Unconjugated
Item Number
Ab006917
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab006917-10μl
10μl
In stock
$66.90

mAb (C11); Mouse anti Human IL-33 Antibody; WB, IHC; Unconjugated

Basic Description

Product NameIL-33 Mouse mAb - Primary antibody, specific to IL33, Mouse IgG2a
SynonymsIL-1F11 | IL-33 | Interleukin-1 family member 11 | NF-HEV | Nuclear factor from high endothelial venules
Specifications & PurityExactAb™, Validated, Carrier Free, Azide Free, High performance, Lot by Lot
Host speciesMouse
SpecificityIL33
ImmunogenRecombinant IL33 expressed in E.coli (AA 112-270).
Positive ControlWB: Jurkat, RAW 264.7, NIH/3T3 and C6 cell lysates. IHC: Human Stomach cancer Tissue, Human Prostate cancer Tissue, Human Colorectal cancer Tissue, Human Breast cancer Tissue, Human Liver Tissue.
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, High Performance, Validated
Note20μl卖完停产,不再备货
Product Description

Mouse anti Human IL-33 Antibody, Monoclonal antibody (C11), could be used for WB, IHC and so on.
Application
WB: 0.01-3µg/mL
IHC: 5-30µg/mL
Protein Function
Cytokine that binds to and signals through the IL1RL1/ST2 receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells. Involved in the maturation of Th2 cells inducing the secretion of T-helper type 2-associated cytokines. Also involved in activation of mast cells, basophils, eosinophils and natural killer cells. Acts as a chemoattractant for Th2 cells, and may function as an "alarmin", that amplifies immune responses during tissue injury.
In quiescent endothelia the uncleaved form is constitutively and abundantly expressed, and acts as a chromatin-associated nuclear factor with transcriptional repressor properties, it may sequester nuclear NF-kappaB/RELA, lowering expression of its targets. This form is rapidely lost upon angiogenic or proinflammatory activation.

Product Properties

IsotypeMouse IgG2a
Light Chain Typekappa
SDS-PAGE150 kDa
Purification MethodProtein A + Protein G affinity chromatography
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 4℃ short term (1-2 weeks). Store at -20℃ long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle.

Images

IL-33 Mouse mAb (Ab006917) - Western Blot
All lanes: IL-33 Mouse mAb (Ab006917) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab138040) at 1/20000 dilution

Predicted band size: 25 kDa
Observed band size: 25 kDa
Exposure time: 150.0 s

IL-33 Mouse mAb (Ab006917) - IHC
DAB staining on IHC
Samples: Human Stomach cancer Tissue
Primary Ab: 30 µg/mL IL-33 Mouse mAb (Ab006917)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.

IL-33 Mouse mAb (Ab006917) - IHC
DAB staining on IHC
Samples: Human Prostate cancer Tissue
Primary Ab: 30 µg/mL IL-33 Mouse mAb (Ab006917)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.

IL-33 Mouse mAb (Ab006917) - IHC
DAB staining on IHC
Samples: Human Colorectal cancer Tissue
Primary Ab: 30 µg/mL IL-33 Mouse mAb (Ab006917)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.

IL-33 Mouse mAb (Ab006917) - IHC
DAB staining on IHC
Samples: Human Breast cancer Tissue
Primary Ab: 30 µg/mL IL-33 Mouse mAb (Ab006917)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.

IL-33 Mouse mAb (Ab006917) - IHC
DAB staining on IHC
Samples: Human Liver Tissue
Primary Ab: 30 µg/mL IL-33 Mouse mAb (Ab006917)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.

Associated Targets(Human)

IL33 Tbio Interleukin-33 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Application

ApplicationDilution info
IHC

5-30 µg/mL

WB

0.01-3 µg/mL

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0102402Certificate of AnalysisJan 10, 2024 Ab006917
ZJ24F0102401Certificate of AnalysisJan 10, 2024 Ab006917
ZJ24F0102400Certificate of AnalysisJan 10, 2024 Ab006917

Related Documents

References

1. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P et al..  (2004)  The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)..  Genome Res,  14  (10B): (2121-7).  [PMID:15489334] [10.1021/op500134e]
2. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K et al..  (2004)  Complete sequencing and characterization of 21,243 full-length human cDNAs..  Nat Genet,  36  (1): (40-5).  [PMID:14702039] [10.1021/op500134e]
3. Osbourn M, Soares DC, Vacca F, Cohen ES, Scott IC, Gregory WF, Smyth DJ, Toivakka M, Kemter AM, le Bihan T et al..  (2017)  HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33..  Immunity,  47  (4): (739-751.e5).  [PMID:29045903] [10.1021/op500134e]
4. Onda, H H and 7 more authors..  (1999)  Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage..  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,      [PMID:10566975]
5. Baekkevold, Espen S ES and 9 more authors..  (2003)  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules..  The American journal of pathology,      [PMID:12819012]
6. Humphray, S J SJ and 147 more authors..  (2004)  DNA sequence and analysis of human chromosome 9..  Nature,    (27):   [PMID:15164053]
7. Schmitz, Jochen J and 12 more authors..  (2005)  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines..  Immunity,      [PMID:16286016]
8. Carriere, Virginie V and 7 more authors..  (2007)  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo..  Proceedings of the National Academy of Sciences of the United States of America,    (2):   [PMID:17185418]
9. Komai-Koma, Mousa M and 5 more authors..  (2007)  IL-33 is a chemoattractant for human Th2 cells..  European journal of immunology,      [PMID:17853410]
10. Küchler, Axel M AM and 8 more authors..  (2008)  Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation..  The American journal of pathology,      [PMID:18787100]
11. Moussion, Christine C, Ortega, Nathalie N and Girard, Jean-Philippe JP..  (2008)  The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?.  PloS one,    (6):   [PMID:18836528]
12. Cayrol, Corinne C and Girard, Jean-Philippe JP..  (2009)  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1..  Proceedings of the National Academy of Sciences of the United States of America,    (2):   [PMID:19439663]
13. Talabot-Ayer, Dominique D, Lamacchia, Céline C, Gabay, Cem C and Palmer, Gaby G..  (2009)  Interleukin-33 is biologically active independently of caspase-1 cleavage..  The Journal of biological chemistry,    (17):   [PMID:19465481]
14. Lüthi, Alexander U AU and 11 more authors..  (2009)  Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases..  Immunity,    (17):   [PMID:19559631]
15. Hayakawa, Morisada M and 5 more authors..  (2009)  Mature interleukin-33 is produced by calpain-mediated cleavage in vivo..  Biochemical and biophysical research communications,    (11):   [PMID:19596270]
16. Lingel, Andreas and 7 more authors..  (2009)  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes..  Structure (London, England : 1993),    (14):   [PMID:19836339]
17. Hong, Jaewoo J and 10 more authors..  (2011)  Identification of constitutively active interleukin 33 (IL-33) splice variant..  The Journal of biological chemistry,    (3):   [PMID:21454686]
18. Ali, Shafaqat S and 6 more authors..  (2011)  The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription..  Journal of immunology (Baltimore, Md. : 1950),    (15):   [PMID:21734074]
19. Kakkar, Rahul R, Hei, Hillary H, Dobner, Stephan S and Lee, Richard T RT..  (2012)  Interleukin 33 as a mechanically responsive cytokine secreted by living cells..  The Journal of biological chemistry,    (24):   [PMID:22215666]
20. Lefrançais, Emma E and 6 more authors..  (2012)  IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G..  Proceedings of the National Academy of Sciences of the United States of America,    (31):   [PMID:22307629]
21. Liu, Xi X and 7 more authors..  (2013)  Structural insights into the interaction of IL-33 with its receptors..  Proceedings of the National Academy of Sciences of the United States of America,    (10):   [PMID:23980170]

Solution Calculators